Phytoconstituents as modulator of inflammatory pathways for COVID ‐19: A comprehensive review and recommendations
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8302 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2024. Written by Pragati Gupta and 2 co-authors. Institution: School of Biotechnology, Shoolini University, Solan, Himachal Pradesh, India. Major MEDLINE topics: COVID-19 Drug Treatment, Inflammation, Phytochemicals, Signal Transduction. Cited 2 times so far (Crossref); 148 references. Funded by: Microsoft.
Abstract (original language)
SARS‐CoV‐2 infection causes disruptions in inflammatory pathways, which fundamentally contribute to COVID‐19 pathophysiology. The present review critically evaluates the gaps in scientific literature and presents the current status regarding the inflammatory signaling pathways in COVID‐19. We propose that phytoconstituents can be used to treat COVID‐19 associated inflammation, several already formulated in traditional medications. For this purpose, extensive literature analysis was conducted in the PubMed database to collect relevant in vitro, in vivo, and human patient studies where inflammation pathways were shown to be upregulated in COVID‐19. Parallelly, scientific literature was screened for phytoconstituents with known cellular mechanisms implicated for inflammation or COVID‐19 associated inflammation. Studies with insufficient evidence on cellular pathways for autophagy and mitophagy were considered out of scope and excluded from the study. The final analysis was visualized in figures and evaluated for accuracy. Our findings demonstrate the frequent participation of NF‐κB, a transcription factor, in inflammatory signaling pathways linked to COVID‐19. Moreover, the MAPK signaling pathway is also implicated in producing inflammatory molecules. Furthermore, it was also analyzed that the phytoconstituents with flavonoid and phenolic backbones could inhibit either the TLR4 receptor or its consecutive signaling molecules, thereby, decreasing NF‐κB activity and suppressing cytokine production. Although, allopathy has treated the early phase of COVID‐19, anti‐inflammatory phytoconstituents and existing ayurvedic formulations may act on the COVID‐19 associated inflammatory pathways and provide an additional treatment strategy. Therefore, we recommend the usage of flavonoids and phenolic phytoconstituents for the treatment of inflammation associated with COVID‐19 infection and similar viral ailments.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Biotechnology, Shoolini University, Solan, Himachal Pradesh, India.
- Department of Pharmacology & Toxicology, Wright State University, Dayton, Ohio, USA.
- School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India.
- National Center cum Department of Human Genome Research Center and Studies, Panjab University, Chandigarh, Punjab, India.
ORCID profiles: Gurjot Kaur
Funding
- Microsoft
Cite
APA
Gupta, P., Dev, K., & Kaur, G. (2024). Phytoconstituents as modulator of inflammatory pathways for COVID ‐19: A comprehensive review and recommendations. Phytotherapy Research. https://doi.org/10.1002/ptr.8302
Vancouver
Gupta P, Dev K, Kaur G. Phytoconstituents as modulator of inflammatory pathways for COVID ‐19: A comprehensive review and recommendations. Phytotherapy Research. 2024. doi:10.1002/ptr.8302
BibTeX
@article{Gupta2024,
author = {Gupta, Pragati and Dev, Kamal and Kaur, Gurjot},
title = {Phytoconstituents as modulator of inflammatory pathways for COVID ‐19: A comprehensive review and recommendations},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8302}
}
EUVIMED